# Keros Therapeutics Inc. (KROS) — Shareholder Equity

## Annual Shareholder Equity (USD)

| Year | Shareholder Equity |
| --- | --- |
| 2025 | $303M |
| 2024 | $572M |
| 2023 | $332M |
| 2022 | $277M |
| 2021 | $243M |
| 2020 | $262M |
| 2019 | -$19M |

Source: [CompaniesByCap](https://companiesbycap.com/company/KROS/shareholders-equity)